Magnetically energized nanoparticles for treating ovarian cancer

Ended Definitive Contract Awarded Last action

Contract number
HHSN261201000069C
Awardee
Awarding agency
Obligated
$200,000

Award facts

Contract value 100% obligated
$200,000.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 18 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Berkeley, CA 94710, USA
Research
SBIR Program Phase I Action

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action 2 $0
Other Administrative Action 1 $0
Original award $200,000

About this award

This is a $200,000 firm fixed-price Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a component of the Department of Health and Human Services, to Aspen Medisys, Inc. The contract is for the development of magnetically energized nanoparticles for treating ovarian cancer. The period of performance runs from the award date of September 24, 2010 through the ultimate completion date of August 23, 2011.

Quick answers

Who was awarded contract HHSN261201000069C?

HHSN261201000069C was awarded to Aspen Medisys, Inc. by National Cancer Institute (National Institutes of Health) on September 24, 2010.

How much is contract HHSN261201000069C worth?

The government has obligated $200,000 on HHSN261201000069C.

Was contract HHSN261201000069C competed?

The extent of competition for HHSN261201000069C was full and open competition after exclusion of sources. The government received 18 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award